{"pub_date": "2016-03-23T00:00:00Z", "subsection_name": null, "lead_paragraph": "A jury upheld the validity of Merck patents in a dispute with Gilead Sciences, which could be forced to hand over a portion of the billions of dollars it has made on hepatitis C drugs.", "print_page": "7", "document_type": "article", "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/03/22/business/0322merckjpg/0322merckjpg-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/03/22/business/0322merckjpg/0322merckjpg-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 405, "url": "images/2016/03/22/business/0322merckjpg/0322merckjpg-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "405", "xlarge": "images/2016/03/22/business/0322merckjpg/0322merckjpg-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/03/22/business/0322merckjpg/0322merckjpg-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/03/22/business/0322merckjpg/0322merckjpg-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "Merck Wins a Drug Patent Claim Against Gilead", "main": "Merck Wins Hepatitis C Drug Patent Claim Against Gilead"}, "source": "The New York Times", "blog": [], "word_count": "385", "web_url": "http://www.nytimes.com/2016/03/23/business/merck-wins-hepatitis-c-drug-patent-claim-against-gilead.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "A jury upheld the validity of Merck patents in a dispute with Gilead Sciences, which could be forced to hand over a portion of the billions of dollars it has made on hepatitis C drugs.", "_id": "56f1eb7838f0d84b0349aa6d", "abstract": "Federal jury backs Merck in dispute with Gilead Sciences over two patents, which could result in Gilead giving Merck part of its billions of dollars in revenue from hepatitis C cure.", "keywords": [{"rank": "1", "name": "subject", "value": "Hepatitis", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Gilead Sciences Inc", "is_major": "Y"}, {"rank": "3", "name": "organizations", "value": "Merck & Company Inc", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Inventions and Patents", "is_major": "Y"}, {"rank": "5", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "6", "name": "subject", "value": "Sovaldi (Drug)", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "Harvoni (Drug)", "is_major": "N"}]}